Matches in Nanopublications for { ?s ?p "DDI between Diltiazem and Cilostazol - Diltiazem, a moderate CYP3A4 inhibitor, may increase the serum concentration of cilostazol by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of cilostazol if diltiazem is initiated, discontinued or dose changed. [drugbank_resource:DB00343_DB01166]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00343_DB01166 label "DDI between Diltiazem and Cilostazol - Diltiazem, a moderate CYP3A4 inhibitor, may increase the serum concentration of cilostazol by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of cilostazol if diltiazem is initiated, discontinued or dose changed. [drugbank_resource:DB00343_DB01166]" assertion.